Table 3 Cox regression results for oncological therapy
From: Use of symptom-focused oncological cancer therapies in hospices: a retrospective analysis
Hazard Ratio | 95% Confidence Interval | p | |
|---|---|---|---|
Oncological therapy | 0.49 | [0.34,0.71] | 0.0001 |
Hospice | 1.03 | [0.87,1.21] | 0.7658 |
Age | 1.01 | [1,1.02] | 0.0115 |
Sex (female) | 0.82 | [0.68,0.99] | 0.0412 |
Gastrointestinal cancer | 0.9 | [0.71,1.14] | 0.3987 |
Gynaecological cancer | 0.83 | [0.63,1.1] | 0.191 |
Haematological systemic disease | 1.41 | [0.95,2.1] | 0.0865 |
Brain cancer | 0.62 | [0.45,0.87] | 0.0052 |
ENT tract cancer | 0.69 | [0.45,1.05] | 0.0808 |
Other cancer | 0.73 | [0.49,1.11] | 0.1426 |
Urological cancer | 0.92 | [0.66,1.29] | 0.6391 |